Research On Kunming Chinese Medicine Factory Co.,Ltd. Development Strategy

Internationalization of Chinese medicine industry has become an inevitable trend, promoting the evolution of modern Chinese medicine industry is the direct source of the momentum of development of modern medicine, traditional Chinese medicine in recent years due to the rapid development of the concept of people's pursuit of health and medicine research capabilities. Although China is the country of consumption of traditional Chinese medicine, medicinal plant resources is much lower than other rich countries, but in recent years in developed countries more and more in-depth study of plant medicine. Chinese medicine products they produce on the market accounted for the vast majority of Chinese medicine share, but also began to enter China's market, is China's medicine industry is facing severe challenges. The face of the pharmaceutical market is being challenged, pharmaceutical companies lack core competencies, basic research in medical science is weak, human resources, lack of funds and other bottlenecks, China's traditional Chinese medicine companies to achieve sustainable development, it was necessary to develop a new strategic plan.Although the industry in kunming Chinese Medicine Factory Co.,Ltd. to maintain a leading level, and achieved good results, but until now the kunming Chinese Medicine Factory Co.,Ltd. has not been a clear strategic plan, the same time, market development, change, the company continues to expand, and the company removal of the whole company must also require a new strategic plan. This paper describes the theory of corporate strategy, based on detailed analysis of kunming Chinese Medicine Factory Co.,Ltd. in the external environment combined pharmaceutical internal conditions, the application of strategic analysis tools for business strengths, weaknesses, competitive environment for industry analysis for the next five years in the pharmaceutical development strategy for planning, while developing a strategy to achieve protection measures with a view to sustainable development in the pharmaceutical Kunming guarantee.